Tactics for companies to survive the Coronavirus crisis
A mix of tactical and strategic ideas that company owner-managers can use to survive the Coronavirus crisis (and plan for life once it’s over).
Don’t let EBITDAC (Earnings before interest, tax, depreciation, amortisation and the effects of COVID-19) become a joke, or a lame excuse for under performance. Instead make it your ally in your fundraising, buyout or exit plans.
Currently, EBITDAC is going to be a key part of discussions with lenders around banking covenants.
In general terms, growing EBITDA grows the value of your business, and M&A advisers usually adjust EBITDA to get to the underlying position. That means adding/subtracting one-off unusual items.
In normal times these might include specific costs relating to the owner manager, relocation costs, one-off consultancy costs, capitalisation of R&D, or perhaps the costs of discontinued activities.
The impact of COVID could be a big add back for most companies when looking at 2020 results. But if you’re going to drive a transaction off EBITDAC, it’s important that you can justify the “C” adjustment.
You must track the impact of COVID on the business and especially cash flow effects. And not just the obvious cash hits, but ongoing additional costs and the lost opportunities as well.
Adjustments need to look convincing to a buyer, funder or lender. The sort of adjustments they’re likely to find convincing might include:
It’s important to keep score, and to measure all these impacts on the business. They’ll be more difficult to isolate and justify if the record has to be constructed later. Consider additional pages in your board pack or management accounts to track the impact of COVID.
The impact of the twin disruptions of COVID and Brexit will linger beyond 2020 and that needs to be tracked too. If you’re looking at business valuation now or considering a transaction in 2021 then forecasts are very important.
Here are some things to consider when testing your forecasts for 2021 and beyond:
Legendary US investor Warren Buffett said “Beware of geeks bearing formulas” and his business partner and Vice Chairman of Berkshire Hathaway is quoted as saying “I think that, every time you see the word EBITDA, you should substitute the word ‘bullshit’ earnings.”
They don’t like EBITDA as it gives scope to manipulate the underlying performance and issues facing a business. For example, Buffett is also credited as having said “Does management think the tooth fairy pays for capital expenditures?” That last point is fair and for a capital-intensive business you’d expect to factor in a further adjustment to an EBITDA-based valuation.
The moral of the story is that EBITDAC is genuinely useful, but that you must be honest and realistic in how you calculate it. It should present the underlying qualities of the business but it’s no use if it’s not believable!